IRVINE, CA -- (Marketwire) -- 03/24/09 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced that the nationally syndicated TV show "The Doctors" is scheduled to broadcast a pediatric cavity preparation performed using BIOLASE's Waterlase® MD(TM) system on Wednesday, March 25.
The procedure was performed live by Dr. Christina Do, DDS, a leading Waterlase Dentist. The entire cavity preparation was rapidly completed without numbing the patient's mouth, and without any reported discomfort.
BIOLASE Chief Executive Officer David Mulder said, "Many of us have had the experience of a shot and a metal drill in our mouth as a child. Those experiences help form our future biases and outlook regarding dentistry. Besides the improved clinical outcomes that Waterlase Dentistry is bringing to the world in a broad variety of procedures, this technology is changing the way our children and the entire next generation will feel about the professionals that ensure their oral care. We believe laser dentistry is becoming an emerging standard, enhancing outcomes and providing a better overall patient experience. We invite you to tune into the Doctors show this Wednesday and to see first hand this new technology and the new positive relationship growing between patients and their dentists. If you have had a painful experience and want to help someone else, join us in letting your family and friends know about the show."
For the show preview, local broadcast times and channels, visit "The Doctors" website at http://www.thedoctorstv.com/main/local_listings. BIOLASE products are exclusively sold in North America through Henry Schein, Inc. (NASDAQ: HSIC).
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.
For further information, please contact:
Allen & Caron